Floatz logo

gc101

SMA - Spinal Muscular Atrophy

GeneCradle Incgene_therapyPhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the SMA - Spinal Muscular Atrophy cohort.

Asset / SponsorPhaseRating
gc101 adeno-associated virus
GeneCradle Inc
Phase 3B

Same molecule, other indications

gc101 is also rated in:

Adverse Drug EventDormant
B
Indicative ·
60 / 100
View asset →
Tumor Infiltrating LymphocytesDormant
B
Indicative ·
59 / 100
View asset →
SafetyDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →